Related Experiment Video
Updated: May 23, 2026
10:58
Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
Published on: August 21, 2019
Malaria vaccine development using synthetic peptides as a technical platform
Giampietro Corradin1, Nora Céspedes, Antonio Verdini
1Biochemstry Department, University of Lausanne, Epalinges, Switzerland.
Advances in Immunology
|March 28, 2012
Summary
Synthetic peptides show promise as malaria vaccine candidates for Plasmodium falciparum and Plasmodium vivax. Advances in solid phase peptide synthesis (SPPS) facilitate the creation of effective malaria vaccines.
Area of Science:
- Immunology
- Vaccinology
- Medicinal Chemistry
Background:
- Malaria remains a significant global health challenge, caused by Plasmodium parasites.
- Developing an effective malaria vaccine is a critical goal for disease control.
Purpose of the Study:
- To review the progress of synthetic peptides as malaria vaccine candidates.
- To highlight the role of solid phase peptide synthesis (SPPS) in peptide vaccine development.
- To discuss complementary strategies for achieving an efficacious malaria vaccine.
Main Methods:
- Literature review of synthetic peptide vaccine development for malaria.
- Analysis of advancements in solid phase peptide synthesis (SPPS).
- Examination of supporting tools and strategies for vaccine efficacy.
Main Results:
- Synthetic peptides have evolved as viable vaccine candidates against Plasmodium falciparum and Plasmodium vivax.
- Solid phase peptide synthesis (SPPS) has enabled routine production of long peptides.
- Progress in complementary tools is crucial for vaccine success.
Conclusions:
- Synthetic peptide-based vaccines represent a promising avenue for malaria prevention.
- Continued innovation in peptide synthesis and vaccine design is essential.
- A multi-faceted approach is necessary to realize a broadly effective malaria vaccine.
Related Concept Videos
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...